CVS Health Magnesium Citrate Laxative Recalled for Bacterial Contamination
CVS Health Magnesium Citrate SALINE LAXATIVE Oral Solution (1.745 g, Lemon Flavor, 10 FL OZ) is being recalled due to microbial contamination with Gluconacetobacter Liquefaciens. Approximately 98,958 bottles distributed nationwide are affected.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall, the agency's most serious classification, indicating a reasonable probability that use or exposure will cause serious adverse health consequences. The presence of Gluconacetobacter Liquefaciens in a pharmaceutical product constitutes a significant microbial hazard.
Plain-English summary
CVS Health Magnesium Citrate SALINE LAXATIVE Oral Solution, 1.745 grams, Lemon Flavor, 10 FL OZ (296 mL), is being recalled by the U.S. Food and Drug Administration due to confirmed microbial contamination.
Testing of the product confirmed the presence of Gluconacetobacter Liquefaciens, a bacterium not permitted in non-sterile pharmaceutical products. The affected lot is Lot 0556808 with an expiration date of 12/2023. Approximately 98,958 bottles have been distributed nationwide in the USA.
The product was distributed by CVS Pharmacy, Inc. (One CVS Drive, Woonsocket, RI 02895) and manufactured by Vi-Jon, LLC. The product UPC is 0 50428 30594 2.
Consumers who have purchased this product should stop using it immediately. Contact CVS Pharmacy or consult a healthcare provider if you have already used this product or have experienced any adverse effects.
The recalled product
- Product
- CVS Health Magnesium Citrate SALINE LAXATIVE, Oral Solution, 1.745 g, Lemon Flavor, 10 FL OZ (296 mL), Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 30594 2.
- Manufacturer
- Vi-Jon, LLC
- Category
- Drug — Oral Laxative
- Hazard
- microbial-contamination
- gluconacetobacter-liquefaciens
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 0556808 Exp. 12/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27